🇺🇸 FDA
Pipeline program

LBR-101 IV

LBR-101-011

Phase 1 mab completed

Quick answer

LBR-101 IV for Bioavailability and Pharmacokinetics is a Phase 1 program (mab) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TEVA PHARMACEUTICAL INDUSTRIES LTD
Indication
Bioavailability and Pharmacokinetics
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials